FdaApplication

NDA 021014

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVARTIS PHARMACEUTICALS CORP
application_typeNDA
approval_date2000-01-14

Products (3)

ProductActive ingredientStrengthDosage form
TRILEPTALOXCARBAZEPINE300MGTABLET;ORAL
TRILEPTALOXCARBAZEPINE600MGTABLET;ORAL
TRILEPTALOXCARBAZEPINE150MGTABLET;ORAL

3 products